Visitors of our website have the opportunity to gain insight of the development of a special, disease-based biobank (SCHIZOBANK). With the aid of this biobank we try to releive the background of this psychiatric disorder at the molecular level. Data of SCHIZOBANK (based on the results of our investigations) contain biomarkers that help diagnosing, monitoring of drugs’ effects and eliminating adverse side effects individually.

News & events

SCHIZOBANK project in the press
Many national newspapers have reported about the project.

2010-11-18 13:17 New experiments involving rats
The consortium plans new experiments involving rats in order to explore the molecular mechanism of antipsychotic drugs’ effects.

2011-01-11 16:25 Number of enrolled patients growing
The number of enrolled persons to the study exceeds five hundred.

2011-03-16 10:31 Extension of the investigations
Project partners decide for the extension of the foregoing investigations with microarray based methods combined with new generation sequencing technologies.

Biobankon alapuló biomarker felfedezése és molekuláris mechanizmuskutatása az antipszichotikus gyógyszerek fejlesztésében című projekt hivatalos oldala.

A projektet a Kutatási és Technológiai Innovációs Alap terhére kiírt Nemzeti Technológiai Program Élettudományok alprogramja útján a Nemzeti Kutatási és Technológiai Hivatal támogatja.

Konzorciumi tagok: UD-GenoMed Kft, Richter Gedeon Nyrt, Debreceni Egyetem, Astrid Research Kft, Magyar Klinikai Neurogenetikai Társaság